fda pulls tirzepatide is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and

Many people assume GLP 1 medications are only for individuals with severe obesity

Though this is comparing different studies and time frames

Clinical data was collected, including sex, age, date of diagnosis, date of death, date of first and second-line chemotherapy treatment and scheme used, anatomical pathology and medical oncology diagnosis, TNM stage, associated co-morbidities, smoking habit, alcoholic habit, ADRs within each recorded cycle, laboratory tests, imaging tests, among others

Madsen, T

It is not approved for human or animal consumption

Manufacturer list prices for FDA-approved branded products in this class are typically $800 to $1,600 per month at U.S